The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

<b>Introduction</b>: Non-small cell lung cancer (NSCLC) is the second most common cancer globally. The mesenchymal-epithelial transition (MET) proto-oncogene can be targeted in NSCLC patients. <b>Methods</b>: We performed a literature search on PubMed in December 2019 for stu...

Full description

Bibliographic Details
Main Authors: Ramon Andrade De Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo-Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Georgios Antoniou
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
NSCLC
MET
targeted therapy
pharmacogenomics
predictive biomarker
Online Access:https://www.mdpi.com/2077-0383/9/6/1918

Internet

https://www.mdpi.com/2077-0383/9/6/1918

Similar Items